Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w)

Loading...
Thumbnail Image
Citations
Scopus:
Altmetric:
Altmetric::
Associated Records
File Licence
Editors
Date
2024-04-01
Source Title
Intensive Care Medicine
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Science and Business Media LLC
Melbourne Authors
Affiliation
Critical Care
Document Type
Journal Article
Subject Code
Citation
Pickkers, P., Angus, D. C., Bass, K., Bellomo, R., van den Berg, E., Bernholz, J., Bestle, M. H., Doi, K., Doig, C. J., Ferrer, R., Francois, B., Gammelager, H., Pedersen, U. G., Hoste, E., Iversen, S., Joannidis, M., Kellum, J. A., Liu, K., Meersch, M. ,... Perez, A. N. (2024). Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL) (Intensive Care Medicine, (2024), 50, 1, (68-78), 10.1007/s00134-023-07271-w). Intensive Care Medicine, 50 (4), pp.614-615. https://doi.org/10.1007/s00134-024-07357-z.
Access Status
Open Access
Access URL
Open Access URL
published version
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Notes
Terms of Use
Keywords
Publisher Licence